Literature DB >> 16179643

Proteomic patterns of preinvasive bronchial lesions.

S M Jamshedur Rahman1, Yu Shyr, Pinar B Yildiz, Adriana L Gonzalez, Huiming Li, Xueqiong Zhang, Pierre Chaurand, Kiyoshi Yanagisawa, Bonnie S Slovis, Robert F Miller, Mathew Ninan, York E Miller, Wilbur A Franklin, Richard M Caprioli, David P Carbone, Pierre P Massion.   

Abstract

PURPOSE: A proteomics approach is warranted to further elucidate the molecular steps involved in lung tumor development. We asked whether we could classify preinvasive lesions of airway epithelium according to their proteomic profile. EXPERIMENTAL
DESIGN: We obtained matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiles from 10-microm sections of fresh-frozen tissue samples: 25 normal lung, 29 normal bronchial epithelium, and 20 preinvasive and 36 invasive lung tumor tissue samples from 53 patients. Proteomic profiles were calibrated, binned, and normalized before analysis. We performed class comparison, class prediction, and supervised hierarchic cluster analysis. We tested a set of discriminatory features obtained in a previously published dataset to classify this independent set of normal, preinvasive, and invasive lung tissues.
RESULTS: We found a specific proteomic profile that allows an overall predictive accuracy of over 90% of normal, preinvasive, and invasive lung tissues. The proteomic profiles of these tissues were distinct from each other within a disease continuum. We trained our prediction model in a previously published dataset and tested it in a new blinded test set to reach an overall 74% accuracy in classifying tumors from normal tissues.
CONCLUSIONS: We found specific patterns of protein expression of the airway epithelium that accurately classify bronchial and alveolar tissue with normal histology from preinvasive bronchial lesions and from invasive lung cancer. Although further study is needed to validate this approach and to identify biomarkers of tumor development, this is a first step toward a new proteomic characterization of the human model of lung cancer tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179643      PMCID: PMC2718455          DOI: 10.1164/rccm.200502-274OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  28 in total

1.  Are all high-grade preinvasive lesions premalignant, and should they all be treated?

Authors:  Anindo K Banerjee; Pamela H Rabbitts; P Jeremy M George
Journal:  Am J Respir Crit Care Med       Date:  2002-05-15       Impact factor: 21.405

Review 2.  Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections.

Authors:  Pierre Chaurand; Sarah A Schwartz; Richard M Caprioli
Journal:  Curr Opin Chem Biol       Date:  2002-10       Impact factor: 8.822

Review 3.  New approaches for biomarker discovery in lung cancer.

Authors:  Rosaura P C Valle; Christine Chavany; Tatyana A Zhukov; Moncef Jendoubi
Journal:  Expert Rev Mol Diagn       Date:  2003-01       Impact factor: 5.225

4.  Direct analysis of laser capture microdissected cells by MALDI mass spectrometry.

Authors:  Baogang J Xu; Richard M Caprioli; Melinda E Sanders; Roy A Jensen
Journal:  J Am Soc Mass Spectrom       Date:  2002-11       Impact factor: 3.109

5.  Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation.

Authors:  Sarah A Schwartz; Michelle L Reyzer; Richard M Caprioli
Journal:  J Mass Spectrom       Date:  2003-07       Impact factor: 1.982

6.  Comparative proteomics analysis of human lung squamous carcinoma.

Authors:  Cui Li; Zhuchu Chen; Zhiqiang Xiao; Xiaoying Wu; Xianquan Zhan; Xiaopeng Zhang; Maoyu Li; JianLing Li; Xueping Feng; Songping Liang; Ping Chen; Jing-yun Xie
Journal:  Biochem Biophys Res Commun       Date:  2003-09-12       Impact factor: 3.575

7.  Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry.

Authors:  Tatyana A Zhukov; Roy A Johanson; Alan B Cantor; Robert A Clark; Melvyn S Tockman
Journal:  Lung Cancer       Date:  2003-06       Impact factor: 5.705

8.  Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction.

Authors:  Sheila A Prindiville; Tim Byers; Fred R Hirsch; Wilbur A Franklin; York E Miller; Kieu O Vu; Holly J Wolf; Anna E Barón; Kenneth R Shroyer; Chan Zeng; Tim C Kennedy; Paul A Bunn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-10       Impact factor: 4.254

9.  Proteomic patterns of tumour subsets in non-small-cell lung cancer.

Authors:  Kiyoshi Yanagisawa; Yu Shyr; Baogang J Xu; Pierre P Massion; Paul H Larsen; Bill C White; John R Roberts; Mary Edgerton; Adriana Gonzalez; Sorena Nadaf; Jason H Moore; Richard M Caprioli; David P Carbone
Journal:  Lancet       Date:  2003-08-09       Impact factor: 79.321

10.  A training-testing approach to the molecular classification of resected non-small cell lung cancer.

Authors:  Noboru Yamagata; Yu Shyr; Kiyoshi Yanagisawa; Mary Edgerton; Thao P Dang; Adriana Gonzalez; Sorena Nadaf; Paul Larsen; John R Roberts; Jonathan C Nesbitt; Roy Jensen; Shawn Levy; Jason H Moore; John D Minna; David P Carbone
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531

View more
  33 in total

Review 1.  Application of glycoproteomics for the discovery of biomarkers in lung cancer.

Authors:  Qing Kay Li; Edward Gabrielson; Hui Zhang
Journal:  Proteomics Clin Appl       Date:  2012-06       Impact factor: 3.494

Review 2.  Pathogenesis of lung cancer: 100 year report.

Authors:  York E Miller
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09       Impact factor: 6.914

Review 3.  Mass spectrometry-based proteomic profiling of lung cancer.

Authors:  Sebahat Ocak; Pierre Chaurand; Pierre P Massion
Journal:  Proc Am Thorac Soc       Date:  2009-04-15

4.  Comprehensive identification of proteins from MALDI imaging.

Authors:  Stefan K Maier; Hannes Hahne; Amin Moghaddas Gholami; Benjamin Balluff; Stephan Meding; Cédrik Schoene; Axel K Walch; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2013-06-19       Impact factor: 5.911

Review 5.  Imaging of intact tissue sections: moving beyond the microscope.

Authors:  Erin H Seeley; Kristina Schwamborn; Richard M Caprioli
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

Review 6.  Evolving concepts in lung carcinogenesis.

Authors:  Brigitte N Gomperts; Avrum Spira; Pierre P Massion; Tonya C Walser; Ignacio I Wistuba; John D Minna; Steven M Dubinett
Journal:  Semin Respir Crit Care Med       Date:  2011-04-15       Impact factor: 3.119

7.  Acyl-coenzyme A-binding protein regulates Beta-oxidation required for growth and survival of non-small cell lung cancer.

Authors:  Fredrick T Harris; S M Jamshedur Rahman; Mohamed Hassanein; Jun Qian; Megan D Hoeksema; Heidi Chen; Rosana Eisenberg; Pierre Chaurand; Richard M Caprioli; Masakazu Shiota; Pierre P Massion
Journal:  Cancer Prev Res (Phila)       Date:  2014-05-12

8.  Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients.

Authors:  Christine H Chung; Erin H Seeley; Heinrich Roder; Julia Grigorieva; Maxim Tsypin; Joanna Roder; Barbara A Burtness; Athanassios Argiris; Arlene A Forastiere; Jill Gilbert; Barbara Murphy; Richard M Caprioli; David P Carbone; Ezra E W Cohen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01-19       Impact factor: 4.254

9.  Staphylococcus aureus elicits marked alterations in the airway proteome during early pneumonia.

Authors:  Christy L Ventura; Roger Higdon; Laura Hohmann; Daniel Martin; Eugene Kolker; H Denny Liggitt; Shawn J Skerrett; Craig E Rubens
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

10.  Comparison of proteomic and transcriptomic profiles in the bronchial airway epithelium of current and never smokers.

Authors:  Katrina Steiling; Aran Y Kadar; Agnes Bergerat; James Flanigon; Sriram Sridhar; Vishal Shah; Q Rushdy Ahmad; Jerome S Brody; Marc E Lenburg; Martin Steffen; Avrum Spira
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.